Using machine learning to predict adverse events in acute coronary syndrome: A retrospective study

Abstract

AbstractBackgroundUp to 30% of patients with acute coronary syndrome (ACS) die from adverse events, mainly renal failure and myocardial infarction (MI). Accurate prediction of adverse events is therefore essential to improve patient prognosis.HypothesisMachine learning (ML) methods can accurately identify risk factors and predict adverse events.MethodsA total of 5240 patients diagnosed with ACS who underwent PCI were enrolled and followed for 1 year. Support vector machine, extreme gradient boosting, adaptive boosting, K‐nearest neighbors, random forest, decision tree, categorical boosting, and linear discriminant analysis (LDA) were developed with 10‐fold cross‐validation to predict acute kidney injury (AKI), MI during hospitalization, and all‐cause mortality within 1 year. Features with mean Shapley Additive exPlanations score >0.1 were screened by XGBoost method as input for model construction. Accuracy, F1 score, area under curve (AUC), and precision/recall curve were used to evaluate the performance of the models.ResultsOverall, 2.6% of patients died within 1 year, 4.2% had AKI, and 4.7% had MI during hospitalization. The LDA model was superior to the other seven ML models, with an AUC of 0.83, F1 score of 0.90, accuracy of 0.85, recall of 0.85, specificity of 0.68, and precision of 0.99 in predicting all‐cause mortality. For AKI and MI, the LDA model also showed good discriminating capacity with an AUC of 0.74.ConclusionThe LDA model, using easily accessible variables from in‐hospital patients, showed the potential to effectively predict the risk of adverse events and mortality within 1 year in ACS patients after PCI.